Document Detail


In vivo assay of folate receptors in nonfunctional pituitary adenomas with 99mTc-folate SPECT/CT.
MedLine Citation:
PMID:  20956474     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
METHODS: Fifty-six patients (29 men, 27 women; age range, 29-82 y) with clinically nonfunctional pituitary adenomas on MRI underwent preoperative imaging using 666 MBq (18 mCi) of (99m)Tc-folate. SPECT/CT images and whole-body and lateral head planar images were acquired approximately 2 h after injection. Surgical resection took place within a week. WBA on a portion of the excised specimens assessed folate receptor expression in 49 patients. Attenuation-corrected (99m)Tc-folate SPECT/CT images were assessed qualitatively and quantitatively (maximal adenoma counts to background), with WBA as a standard.
RESULTS: Integrated CT was useful for uptake localization and assisted region-of-interest placement. Qualitative interpretation of planar imaging yielded a sensitivity of 81% and specificity of 72%. Qualitative SPECT/CT yielded a sensitivity of 94% and specificity of 61%. Receiver-operating-characteristic curve analysis of quantitative uptake yielded a tumor-to-background cutoff ratio of 3.5, with a sensitivity of 81% and specificity of 83%. Scalp uptake yielded consistent results (over the brain, neck, and choroid plexus) for background when SPECT/CT misalignment artifacts were avoided. Detection of pituitary uptake on anterior-posterior and lateral images was hampered by facial uptake, which varied between patients.
CONCLUSION: SPECT/CT of (99m)Tc-folate is an accurate method of assaying folate receptors in vivo and may provide a quantitative marker for identifying folate receptor-positive tumors. This method may also prove beneficial in selecting patients for folate-targeted therapy of clinically nonfunctional pituitary adenomas, for which there is currently no medical therapy.
Authors:
James R Galt; Raghuveer K Halkar; Chheng-Orn Evans; Naema A Osman; David LaBorde; Timothy H Fox; Bajat A Faraj; Kush Kumar; Houping Wang; Nelson M Oyesiku
Related Documents :
11012424 - Cost-effectiveness of functional imaging tests in the diagnosis of alzheimer disease.
18199624 - Spect study of folate receptor-positive malignant and normal tissues in mice using a no...
2980514 - Single photon emission computed tomography of brain tumors with 201tic1.
14516544 - A comparative study of 511 kev spect and pet using separate 370 mbq f-18-fdg doses on d...
11081654 - Mosquito larvicidal activity of pipernonaline, a piperidine alkaloid derived from long ...
19774144 - Pictorial essay: mri of the fetal brain.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-10-18
Journal Detail:
Title:  Journal of nuclear medicine : official publication, Society of Nuclear Medicine     Volume:  51     ISSN:  1535-5667     ISO Abbreviation:  J. Nucl. Med.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-05     Completed Date:  2010-12-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0217410     Medline TA:  J Nucl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1716-23     Citation Subset:  IM    
Affiliation:
Department of Radiology, Emory University, Atlanta, Georgia 30322, USA. jgalt@emory.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Female
Folate Receptors, GPI-Anchored / metabolism*
Folic Acid / drug effects*
Humans
Male
Middle Aged
Organotechnetium Compounds / diagnostic use*
Pituitary Neoplasms / diagnosis*,  metabolism*,  radiography,  radionuclide imaging
ROC Curve
Sensitivity and Specificity
Tomography, Emission-Computed, Single-Photon*
Tomography, X-Ray Computed*
Grant Support
ID/Acronym/Agency:
NS051439-03/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Folate Receptors, GPI-Anchored; 0/Organotechnetium Compounds; 59-30-3/Folic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Are health economics making us sick?
Next Document:  PET of tumor CXCR4 expression with 4-18F-T140.